Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 42708-194

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 42708-194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (42708 194 30 Label)

This text provides information about Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg. It indicates the dosage instructions for taking this medication.*

FDA Label Image

Figure (Venlafaxine Fig1)

FDA Label Image

Figure (Venlafaxine Fig2)

This text seems to list various drugs along with their corresponding PK (pharmacokinetic) fold change and 90% CI (confidence interval) values. It seems to be discussing the interactions of these drugs, possibly in context of their pharmacokinetics. The provided text could be used to study how these drugs may affect each other's metabolism in a given system.*

FDA Label Image

Figure (Venlafaxine Fig3)

This is a list of drugs and analytes that have potential interactions with each other. The list includes drugs like ethanol, aprazolam, indinavir, metoprolol, risperidone, haloperidol, caffeine, tolbutamide, and lithium. The text also mentions various analytes such as diazepam, desmetyldiazepam, alprazolam, imipramine, desipramine, and haloperidol. Additionally, it provides information on PK parameters like Cmax and AU, as well as Fold Change and 90% CI values related to these interactions.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.